A new formulation of the COMIRNATY booster "12 years of age and older, Ready
to use (Original/Omicron BA.1 Cap and Package, Multi-dose vial)" was approved
on DD/MM/YY with procedure X/0000.Additional website content relevant to this
new formulation will be available on DD/MM/YY.
COMIRNATY Original/Omicron BA.1 15/15 micrograms/per dose for dispersion
for injection, for 12 years of age and older, Ready to use (Original/Omicron BA.1
Cap and Package, Multi-dose vial)
PP-CMR-GLB-0188

This site is intended for Healthcare Professionals.

Menu

Close

HomeShelf Life & StorageDosing & Administration12 years of age and older5 through 11 years of age6 months through 4 years of ageSafety & EfficacyResources

Pfizer-BioNTech COVID-19 Vaccine Authorized for Emergency Use: 
The Pfizer- BioNTech COVID - 19 have been conditionally authorized by Saudi Food and Drug authority .Emergency uses of the vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 6 months  of age and older. The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.

 

12 years of age and older
Dosing & Administration
Shelf Life & Storage
5 through 11 years of age
Dosing & Administration
Shelf Life & Storage
6 months through 4 years of age
Dosing & Administration
Shelf Life & Storage
Vaccine Formulations GuideChildren 6 months through 4 years of age should only be vaccinated with the 6 months through 4 years of age Dilute Before Use Maroon Cap presentation. No other vaccine presentation should be used for children 6 months through 4 years of age because of the potential for vaccine administration errors, including dosing errors. For children who will turn from 4 years to 5 years of age between any doses in the primary series, consult the EUA Fact Sheets for Vaccination Providers.

Children ages 5 through 11 years old should only be vaccinated with the 5 through 11 years of age Dilute Before Use Orange Cap presentation. No other vaccine presentation should be used for children 5 through 11 years old because of the potential for vaccine administration errors, including dosing errors. For children who will turn 12 between their first and second dose, consult the EUA Fact Sheets for Vaccination Providers.

The 2 formulations of Pfizer-BioNTech COVID-19 Vaccine, 12 years of age and older Dilute Before Use Purple Cap and 12 years of age and older Do Not Dilute Gray Cap, when prepared according to their respective instructions for use, can be used interchangeably and are indicated for primary series only.

Pfizer-BioNTech COVID-19 Vaccine 12 years of age and older Do Not Dilute, Bivalent (Original and Omicron BA.4/BA.5) Gray Cap and 5 through 11 years of age Dilute Before Use, Bivalent (Original and Omicron BA.4/BA.5) Orange Cap are only indicated as a single booster dose.

Refer to the information outlined below to understand the differences across age groups and formulations

Formulation

12 years of age and older
​​​​​​​ Dilute Before Use

12 years of age and older
​​​​​​​Do Not Dilute

12 years of age and older
Do Not Dilute, Bivalent (Original and Omicron BA.4/BA.5)

5 through 11 years of age
​​​​​​​Dilute Before Use

5 through 11 years of age
Dilute Before Use, Bivalent (Original and Omicron BA.4/BA.5)

6 months through 4 years of age
Dilute Before Use

Vial

Multi-dose Vial

Multi-dose Vial

Single- and Multi-dose Vial

Multi-dose Vial

Multi-dose Vial

Multi-dose Vial

Vial Cap Color

Purple

Gray

Gray

Orange

Orange

Maroon

EUA Fact Sheet for Vaccination Providers

EUA Fact Sheet for Vaccination Providers

EUA Fact Sheet for Vaccination Providers

EUA Fact Sheet for Vaccination Providers

EUA Fact Sheet for Vaccination Providers

EUA Fact Sheet for Vaccination Providers

EUA Fact Sheet for Vaccination Providers

Dosage

30 mcg

30 mcg

Original 15 mcg and Omicron BA.4/BA.5 15 mcg

10 mcg

Original 5 mcg and Omicron BA.4/BA.5 5 mcg

3 mcg

Injection Volume per Dose

0.3 mL

0.3 mL

0.3 mL

0.2 mL

0.2 mL

0.2 mL

Dilution

Dilution required

NO DILUTION

NO DILUTION

Dilution required

Dilution required

Dilution required

Amount of Diluent
Needed per Vial*

1.8 mL

NO DILUTION

NO DILUTION

1.3 mL

1.3 mL

2.2 mL

Doses per Vial

6 doses per vial
(after dilution)

6 doses per vial

Single-dose Vial: 1 dose per vial
Multi-dose Vial: 6 doses per vial

10 doses per vial
(after dilution)

10 doses per vial
(after dilution)

10 doses per vial
(after dilution)

Fill Volume per Vial

0.45 mL

2.25 mL

2.25 mL

1.3 mL

1.3 mL

0.4 mL

Storage 

Conditions

Ultra-Low-Temperature (ULT) Freezer (-90°C to -60°C)

18 months (shelf life)a

18 months (shelf life)b

18 months (shelf life)b

18 months (shelf life)b

18 months (shelf life)b

18 months (shelf life)b

Freezer Storage Time
(-25°C to -15°C) 

2 weeks

DO NOT STORE

DO NOT STORE

DO NOT STORE

DO NOT STORE

DO NOT STORE

Refrigeration Storage Time
(2°C to 8°C) 

1 month

10 weeks

10 weeks

10 weeks

10 weeks

10 weeks

Room Temperature
​​​​​​​(8°C to 25°C)

2 hours prior to dilution
(including any thaw time)

12 hours prior to first puncture
​​​​​​​(including any thaw time)

12 hours prior to first puncture
​​​​​​​(including any thaw time)

12 hours prior to dilution
(including any thaw time)

12 hours prior to dilution
(including any thaw time)

12 hours prior to dilution
(including any thaw time)

After First Puncture
​​​​​​​(2°C to 25°C)

Discard after 6 hours

Discard after 12 hours

Discard after 12 hours

Discard after 12 hours

Discard after 12 hours

Discard after 12 hours

Package Size

195 vials

10 vials

10 single-dose vials or 10 multi-dose vials

10 vials

10 vials

10 vials

*Diluent: sterile 0.9% Sodium Chloride Injection, USP. Bacteriostatic saline or other diluents must NOT be used.
aRegardless of storage condition, vaccine should not be used past the 18-month expiry (6 months printed on the vial plus additional 12 months for the expiry dates December 2021 through March 2022. 9 months printed on the vial plus additional 9 months for the expiry dates June 2022 through December 2022. 
bRegardless of storage condition, vaccines should not be used after 18 months from the date of manufacture printed on the vial and cartons.

DOWNLOAD THIS GUIDE

Pfizer-BioNTech COVID-19 Vaccine
Authorised Use

Pfizer-BioNTech COVID-19 Vaccine is authorised for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months of age and older.  

Interchangeability (Primary Series for Individuals 12 Years of Age and Older)
When prepared according to their respective instructions for use, the EUA-authorised Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older can be used interchangeably without presenting any safety or effectiveness concerns. 
Because of the potential for vaccine administration errors, including dosing errors, vaccine presentations should only be used for the ages specified on the vial labels, cartons, or the respective age-based Fact Sheet. The information in the Fact Sheets supersedes the information printed on the vial labels and cartons.

Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) 
Authorised Use

Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5), hereafter referred to as Pfizer-BioNTech COVID-19 Vaccine, Bivalent is authorised for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 5 years of age and older.

Ensuring the Authenticity of Pfizer-BioNTech COVID-19 Vaccine
  • Pfizer is committed to patient safety and ensuring that people have accurate information about the vaccine, including how it is accessed and administered. We are actively monitoring for fraudulent offers of illegitimate vaccines to protect patients from products that might be dangerous and lead to serious and life-threatening harm

    • The vaccine is only administered intramuscularly by a healthcare professional

    • The vaccine is not taken orally and is not available in a capsule or tablet form

  • Authentic vaccines, manufactured by Pfizer Inc., will include the Pfizer and BioNTech names on the label and are dispensed in a vial as follows:

    • For 12 years of age and older Dilute Before Use, Purple Cap, two versions of the vial label are in current circulation - with or without a purple border

    • For 12 years of age and older Do Not Dilute, Gray Cap, the vial label includes a gray border

    • For 12 years of age and older Do Not Dilute, Bivalent (Original and Omicron BA.4/BA.5), Gray Cap, the vial label includes a gray border

    • For 5 through 11 years of age Dilute Before Use, Orange Cap, the vial label includes an orange border

    • For 5 through 11 years of age Dilute Before Use, Bivalent (Original and Omicron BA.4/BA.5), Orange Cap, the vial label includes an orange border

    • For 6 months through 4 years of age Dilute Before Use, Maroon Cap, the vial label includes a maroon border

  • Ensure the safety of the vaccine vials by limiting access to only authorised personnel. The location they are stored in must be secure and locked when not in use. To prevent counterfeits, discard vaccine vials in sharps containers and empty vial cartons as medical waste or deface or safely crush all materials so they cannot be reused. Remember, the vaccines are only available through government-authorised vaccination centers – such as doctor’s offices, authorised pharmacies, outpatient clinics, community vaccination locations, and hospitals. The vaccine can only be administered by licensed healthcare professionals, or other individuals that are approved vaccinators, at government-authorised vaccination sites. Individual doses are not for sale

     

For more information ​​​​​​​

Contact  Pfizermedicalinformation.com
 

Contact

EUA Fact Sheet Updates

Please be aware that Pfizer-BioNTech COVID-19 Vaccine is now available in 6 formulations. For additional information on differences across age groups and formulations, please see Vaccine Formulations Guide on the home page of this website.

Label Update: Effective 22 December 2022


Updated shelf life for all formulations. Please see the Shelf Life & Storage page of this website for more information.

Available data supporting transportation of thawed vials increased up to 48 hours.


Click below to view:
    •    EUA Fact Sheet for Vaccination Providers
- 12 years of age and older Dilute Before Use, Purple Cap
    •    EUA Fact Sheet for Vaccination Providers - 12 years of age and older Do Not Dilute, Gray Cap
    •    EUA Fact Sheet for Vaccination Providers - 12 years of age and older Do Not Dilute, Bivalent (Original and Omicron BA.4/BA.5), Gray Cap
    •    EUA Fact Sheet for Vaccination Providers - 5 through 11 years of age Dilute Before Use, Orange Cap
    •    EUA Fact Sheet for Vaccination Providers - 5 through 11 years of age Dilute Before Use, Bivalent (Original and Omicron BA.4/BA.5), Orange Cap
    •    EUA Fact Sheet for Vaccination Providers - 6 months through 4 years of age Dilute Before Use, Maroon Cap
 

For healthcare professionals only